Amicus, Shire enter into potential $440 million deal Avandia sales falling as doctors prescribe alternatives Mirixa announces launch of MirixaPro 2.3 MTM program for pharmacists Remicade usage hits 1 million mark Watson files application with FDA for generic YAZ Giant Eagle to expand $4 generic prescription program New vaccine may make hypertension a thing of the past Novo Nordisk, undaunted by Exubera's performance, continues developing AERx Allergan and Stiefel partner over tazarotene Research indicates that parents are uncomfortable with EpiPen First Previous 2651 2652 2653 2654 2655 Next Last
